UBS Group’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-37,627
| Closed | -$183K | – | 7575 |
|
|
2020
Q1 | $183K | Sell |
37,627
-22,465
| -37% | -$109K | ﹤0.01% | 3959 |
|
|
2019
Q4 | $639K | Sell |
60,092
-100,562
| -63% | -$1.07M | ﹤0.01% | 3699 |
|
|
2019
Q3 | $1.67M | Buy |
160,654
+82,154
| +105% | +$856K | ﹤0.01% | 2775 |
|
|
2019
Q2 | $1.2M | Buy |
78,500
+32,374
| +70% | +$496K | ﹤0.01% | 2913 |
|
|
2019
Q1 | $592K | Sell |
46,126
-60,488
| -57% | -$776K | ﹤0.01% | 3261 |
|
|
2018
Q4 | $1.01M | Buy |
106,614
+73,155
| +219% | +$695K | ﹤0.01% | 2984 |
|
|
2018
Q3 | $555K | Buy |
33,459
+9,506
| +40% | +$158K | ﹤0.01% | 3575 |
|
|
2018
Q2 | $385K | Sell |
23,953
-27,924
| -54% | -$449K | ﹤0.01% | 3716 |
|
|
2018
Q1 | $793K | Buy |
51,877
+40,304
| +348% | +$616K | ﹤0.01% | 3193 |
|
|
2017
Q4 | $181K | Buy |
11,573
+1,912
| +20% | +$29.9K | ﹤0.01% | 4089 |
|
|
2017
Q3 | $107K | Sell |
9,661
-15,698
| -62% | -$174K | ﹤0.01% | 4407 |
|
|
2017
Q2 | $234K | Sell |
25,359
-1,586
| -6% | -$14.6K | ﹤0.01% | 3818 |
|
|
2017
Q1 | $230K | Buy |
26,945
+15,232
| +130% | +$130K | ﹤0.01% | 3750 |
|
|
2016
Q4 | $126K | Buy |
11,713
+3,402
| +41% | +$36.6K | ﹤0.01% | 4255 |
|
|
2016
Q3 | $90K | Buy |
8,311
+811
| +11% | +$8.78K | ﹤0.01% | 4205 |
|
|
2016
Q2 | $51K | Hold |
7,500
| – | – | ﹤0.01% | 4661 |
|
|
2016
Q1 | $35K | Buy |
7,500
+486
| +7% | +$2.27K | ﹤0.01% | 4966 |
|
|
2015
Q4 | $44K | Buy |
7,014
+864
| +14% | +$5.42K | ﹤0.01% | 4847 |
|
|
2015
Q3 | $54K | Sell |
6,150
-2,300
| -27% | -$20.2K | ﹤0.01% | 4666 |
|
|
2015
Q2 | $99K | Buy |
8,450
+5,100
| +152% | +$59.8K | ﹤0.01% | 4308 |
|
|
2015
Q1 | $48K | Hold |
3,350
| – | – | ﹤0.01% | 4699 |
|
|
2014
Q4 | $57K | Buy |
+3,350
| New | +$57K | ﹤0.01% | 4618 |
|